Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorena Landuzzi

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Oncotarget|November 27, 2014
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasLorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, et al.
International Journal of Cancer|February 10, 2007
Inhibition of prostate carcinogenesis by combined active immunoprophylaxisCarla De Giovanni, Stefania Croci, Giordano Nicoletti, et al.
Plos One|June 28, 2012
Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitorPatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
BMC Cancer|March 1, 2014
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomasClara Guerzoni, Stefano Amatori, Luca Giorgi, et al.
Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2011
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PETMaria Abbondanza Pantaleo, Giordano Nicoletti, Cristina Nanni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2009
High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapyPatrizia Nanni, Giordano Nicoletti, Lorena Landuzzi, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Cancer Immunology Research|December 5, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and MacrophagesMaria Cristina Manara, Cristina Manferdini, Camilla Cristalli, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Oncotarget|November 27, 2014
Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomasLorena Landuzzi, Marianna L Ianzano, Giordano Nicoletti, et al.
International Journal of Cancer|February 10, 2007
Inhibition of prostate carcinogenesis by combined active immunoprophylaxisCarla De Giovanni, Stefania Croci, Giordano Nicoletti, et al.
Plos One|June 28, 2012
Multiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitorPatrizia Nanni, Giordano Nicoletti, Arianna Palladini, et al.
BMC Cancer|March 1, 2014
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomasClara Guerzoni, Stefano Amatori, Luca Giorgi, et al.
Oncogenesis|November 14, 2021
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progressionVeronica Giusti, Francesca Ruzzi, Lorena Landuzzi, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 4, 2011
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PETMaria Abbondanza Pantaleo, Giordano Nicoletti, Cristina Nanni, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2009
High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapyPatrizia Nanni, Giordano Nicoletti, Lorena Landuzzi, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Cancer Immunology Research|December 5, 2023
Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and MacrophagesMaria Cristina Manara, Cristina Manferdini, Camilla Cristalli, et al.
Cancers|January 10, 2026
Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center ExperienceAlessandro Parra, Emanuela Palmerini, Maria Antonella Laginestra, et al.
Pageof 9